|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.450 USD | +0.41% |
|
+7.71% | +35.83% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 197M 171M 160M 146M 276M 18.73B 279M 1.87B 733M 9.36B 738M 722M 31.14B | P/E 2026 * |
12.5x | P/E 2027 * | 48.8x |
|---|---|---|---|---|---|
| Enterprise Value | 197M 171M 160M 146M 276M 18.73B 279M 1.87B 733M 9.36B 738M 722M 31.14B | EV / Sales 2026 * |
2.51x | EV / Sales 2027 * | 2.91x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | +0.61% | ||
| 1 week | +7.71% | ||
| Current month | +3.16% | ||
| 1 month | +6.30% | ||
| 3 months | +21.04% | ||
| 6 months | -15.40% | ||
| Current year | +35.83% |
| 1 week | 2.2 |  | 2.48 |
| 1 month | 2.2 | | 2.48 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.46 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 29/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 23/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 30/06/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 31/10/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 29/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Buy | Chief Executive Officer | 56,000 | 0.0696% | ||
| 18/11/25 | Sell | Director | 168 | 0.0002% | ||
| 03/09/25 | Free | Chief Operating Officer | 75,000 | 0.0941% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.41% | +7.71% | +65.20% | +28.68% | 197M | |
| +1.04% | +2.07% | +57.95% | +159.62% | 1,043B | |
| -0.54% | +0.18% | +50.24% | +48.06% | 621B | |
| -1.40% | -5.52% | +23.89% | +61.78% | 435B | |
| 0.00% | +3.20% | +46.70% | +37.70% | 361B | |
| +0.58% | -1.26% | +35.52% | +39.32% | 293B | |
| -1.55% | -6.84% | +7.20% | +8.86% | 251B | |
| -1.37% | +3.75% | +41.28% | +59.00% | 220B | |
| -0.24% | -11.27% | +1.42% | -46.20% | 201B | |
| -2.02% | -1.39% | +17.39% | +60.48% | 164B | |
| Average | -0.44% | -2.68% | +34.68% | +45.73% | 358.93B | |
| Weighted average by Cap. | -0.19% | -3.79% | +39.93% | +73.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 67.95M 63.62M 58.2M 110M 7.46B 111M 744M 292M 3.73B 294M 288M 12.4B | 67.56M 58.63M 54.9M 50.22M 94.81M 6.44B 96.05M 642M 252M 3.22B 254M 248M 10.7B |
| Net income | 15.72M 13.64M 12.78M 11.69M 22.06M 1.5B 22.35M 149M 58.66M 748M 59.03M 57.75M 2.49B | 4.07M 3.53M 3.31M 3.03M 5.72M 388M 5.79M 38.72M 15.2M 194M 15.29M 14.96M 645M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | US$2.440 | 0.00% | 273,603 |
| 05/08/26 | US$2.440 | +2.95% | 538,936 |
| 04/08/26 | US$2.370 | +2.16% | 716,163 |
| 03/08/26 | US$2.320 | -2.11% | 1,027,427 |
| 31/07/26 | US$2.370 | +4.41% | 1,232,753 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
